0001127602-17-034707.txt : 20171214 0001127602-17-034707.hdr.sgml : 20171214 20171214172602 ACCESSION NUMBER: 0001127602-17-034707 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171213 FILED AS OF DATE: 20171214 DATE AS OF CHANGE: 20171214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANSTICE DAVID W CENTRAL INDEX KEY: 0001181171 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 171257011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-12-13 0001520262 Alkermes plc. ALKS 0001181171 ANSTICE DAVID W CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 Ordinary Shares 2017-12-13 4 M 0 20000 11.44 A 35000 D Ordinary Shares 2017-12-13 4 M 0 20000 11.44 A 55000 D Non Qualified Stock Option (Right to Buy) 11.44 2017-12-13 4 M 0 20000 0 D 2018-10-07 Ordinary Shares 20000 0 D Non Qualified Stock Option (Right to Buy) 11.44 2017-12-13 4 M 0 20000 0 D 2018-10-07 Ordinary Shares 20000 0 D These options are fully vested in accordance with their terms. /s/ Jennifer Baptiste, attorney-in-fact for David W. Anstice 2017-12-14